FDA Brief

Warning letters Food

FDA warning letter to

1st Phorm LLC

High riskIssued Jul 29, 2021Posted Aug 17, 2021Office of Human and Animal Food West Division II

FDA warned 1st Phorm that its heart supplements were unapproved drugs and some supplements contained unsafe hordenine.

What happened

FDA reviewed www.1stphorm.com in March 2021 and found claims that Whole Heart Cardiovascular Health Formula and Full-Mega Omega-3 Fish Oil treat or prevent diseases such as heart disease, high blood pressure, ADHD, depression, asthma, and psoriasis, making them unapproved new drugs. FDA also found that MegaWatt V2, Thyro-Drive, 1-Db Overdrive Fastpack, 1-Db Goddess, and 1-Db Overdrive & Thyro-Drive list hordenine, a new dietary ingredient (not marketed in the U.S. before 1994) for which no required safety notification was submitted, and FDA called those products adulterated, meaning illegal because of that ingredient.

What FDA found

  1. The website claimed Whole Heart and Full-Mega Omega-3 treat or prevent diseases such as heart disease, high blood pressure, ADHD, depression, asthma, and psoriasis, so FDA treats them as unapproved new drugs.

    21 U.S.C. 321(g)(1)(B); 21 U.S.C. 331(d), 355(a)
  2. The two products are misbranded because they lack adequate directions for use by a layperson for diseases that require a licensed practitioner.

    21 U.S.C. 352(f)(1); 21 CFR 201.5
  3. Five products list hordenine, a new dietary ingredient, without the required premarket safety notification to FDA.

    21 U.S.C. 350b(a)(2); 21 CFR 190.6
  4. FDA said there is no history of use or evidence showing hordenine is reasonably expected to be safe, so supplements containing it are adulterated.

    21 U.S.C. 342(f)(1)(B)
  5. Introducing these misbranded drugs and adulterated supplements into interstate commerce is prohibited.

    21 U.S.C. 331(a), (v)

What FDA wants

FDA asked the company to notify it in writing within 15 working days of the specific steps taken to fix the violations and prevent recurrence, with related documentation, or to explain why more time is needed. If the company believes the products are not in violation, it must include its reasoning and supporting information.

Who should pay attention

  • retailers and online marketplaces selling 1st Phorm supplements
  • brands that use hordenine or other new dietary ingredients
  • quality teams reviewing supplement claims and ingredient safety notifications

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk